Gene therapy patients monitored for 5 years after bladder treatment
NCT ID NCT07227285
Summary
This study follows 16 people for five years after they received an experimental gene therapy called EG110A for bladder control problems caused by spinal cord injury. Researchers want to understand the long-term safety of this treatment and see how long its benefits last. Participants will report their quality of life and when they need alternative treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rancho Los Amigos National Rehabilitation Center
Downey, California, 90242, United States
Contact
-
Sidney Kimmel Medical College
Philadelphia, Pennsylvania, 19107, United States
Contact
-
UTHealth Houston / TIRR Memorial Hermann
Houston, Texas, 77030, United States
Contact
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
Contact
Conditions
Explore the condition pages connected to this study.